Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.
Clinical trial NCT03990051 · COMPLETED
Trial details
- NCT number
- NCT03990051
- Sponsor
- Glia, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2021-10-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.